
[Federal Register Volume 81, Number 189 (Thursday, September 29, 2016)]
[Notices]
[Page 66967]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-23514]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2013-D-1143]


Use of Nucleic Acid Tests To Reduce the Risk of Transmission of 
West Nile Virus From Living Donors of Human Cells, Tissues, and 
Cellular and Tissue-Based Products; Guidance for Industry; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of availability; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or Agency) is correcting 
a notice that appeared in the Federal Register of Tuesday, September 
13, 2016 (81 FR 62910). The document announced the availability of a 
guidance for industry entitled ``Use of Nucleic Acid Tests to Reduce 
the Risk of Transmission of West Nile Virus from Living Donors of Human 
Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). The 
document was published with incorrect information of a comment period 
due date. This document corrects that error.

FOR FURTHER INFORMATION CONTACT: Jonathan McKnight, Center for 
Biologics Evaluation and Research, Food and Drug Administration, 10903 
New Hampshire Ave., Bldg. 71, Rm. 7301, Silver Spring, MD 20993-0002, 
240-402-7911.

SUPPLEMENTARY INFORMATION: In the Federal Register of September 13, 
2016, in FR Doc. 2016-21969, on page 62910, the following correction is 
made:
    On page 62910, in the first column under the DATES: caption, the 
sentence is corrected to read, ``Submit either electronic or written 
comments on Agency guidances at any time.''

    Dated: September 23, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016-23514 Filed 9-28-16; 8:45 am]
 BILLING CODE 4164-01-P


